rs3812153

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022726.4(ELOVL4):​c.895A>G​(p.Met299Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.137 in 1,613,932 control chromosomes in the GnomAD database, including 18,505 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: 𝑓 0.16 ( 2242 hom., cov: 33)
Exomes 𝑓: 0.13 ( 16263 hom. )

Consequence

ELOVL4
NM_022726.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.91

Publications

47 publications found
Variant links:
Genes affected
ELOVL4 (HGNC:14415): (ELOVL fatty acid elongase 4) This gene encodes a membrane-bound protein which is a member of the ELO family, proteins which participate in the biosynthesis of fatty acids. Consistent with the expression of the encoded protein in photoreceptor cells of the retina, mutations and small deletions in this gene are associated with Stargardt-like macular dystrophy (STGD3) and autosomal dominant Stargardt-like macular dystrophy (ADMD), also referred to as autosomal dominant atrophic macular degeneration. [provided by RefSeq, Jul 2008]
ELOVL4 Gene-Disease associations (from GenCC):
  • Stargardt disease 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • spinocerebellar ataxia type 34
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Orphanet
  • Stargardt disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0042957664).
BP6
Variant 6-79916658-T-C is Benign according to our data. Variant chr6-79916658-T-C is described in ClinVar as Benign. ClinVar VariationId is 137206.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.343 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ELOVL4NM_022726.4 linkc.895A>G p.Met299Val missense_variant Exon 6 of 6 ENST00000369816.5 NP_073563.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ELOVL4ENST00000369816.5 linkc.895A>G p.Met299Val missense_variant Exon 6 of 6 1 NM_022726.4 ENSP00000358831.4

Frequencies

GnomAD3 genomes
AF:
0.160
AC:
24394
AN:
152110
Hom.:
2243
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.231
Gnomad AMI
AF:
0.179
Gnomad AMR
AF:
0.162
Gnomad ASJ
AF:
0.101
Gnomad EAS
AF:
0.201
Gnomad SAS
AF:
0.357
Gnomad FIN
AF:
0.114
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.111
Gnomad OTH
AF:
0.133
GnomAD2 exomes
AF:
0.167
AC:
41850
AN:
251258
AF XY:
0.173
show subpopulations
Gnomad AFR exome
AF:
0.235
Gnomad AMR exome
AF:
0.176
Gnomad ASJ exome
AF:
0.0976
Gnomad EAS exome
AF:
0.206
Gnomad FIN exome
AF:
0.117
Gnomad NFE exome
AF:
0.114
Gnomad OTH exome
AF:
0.142
GnomAD4 exome
AF:
0.135
AC:
197170
AN:
1461704
Hom.:
16263
Cov.:
32
AF XY:
0.141
AC XY:
102534
AN XY:
727156
show subpopulations
African (AFR)
AF:
0.236
AC:
7895
AN:
33474
American (AMR)
AF:
0.176
AC:
7846
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.0975
AC:
2547
AN:
26134
East Asian (EAS)
AF:
0.204
AC:
8103
AN:
39694
South Asian (SAS)
AF:
0.350
AC:
30172
AN:
86250
European-Finnish (FIN)
AF:
0.117
AC:
6223
AN:
53412
Middle Eastern (MID)
AF:
0.130
AC:
752
AN:
5766
European-Non Finnish (NFE)
AF:
0.112
AC:
124820
AN:
1111880
Other (OTH)
AF:
0.146
AC:
8812
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
9439
18878
28316
37755
47194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4850
9700
14550
19400
24250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.160
AC:
24411
AN:
152228
Hom.:
2242
Cov.:
33
AF XY:
0.163
AC XY:
12153
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.230
AC:
9570
AN:
41520
American (AMR)
AF:
0.162
AC:
2476
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.101
AC:
352
AN:
3468
East Asian (EAS)
AF:
0.200
AC:
1038
AN:
5182
South Asian (SAS)
AF:
0.357
AC:
1721
AN:
4826
European-Finnish (FIN)
AF:
0.114
AC:
1210
AN:
10604
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.111
AC:
7569
AN:
68014
Other (OTH)
AF:
0.133
AC:
281
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1022
2044
3067
4089
5111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
268
536
804
1072
1340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.127
Hom.:
6294
Bravo
AF:
0.163
TwinsUK
AF:
0.116
AC:
431
ALSPAC
AF:
0.116
AC:
448
ESP6500AA
AF:
0.229
AC:
1008
ESP6500EA
AF:
0.109
AC:
939
ExAC
AF:
0.171
AC:
20786
Asia WGS
AF:
0.276
AC:
961
AN:
3478
EpiCase
AF:
0.110
EpiControl
AF:
0.113

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Dec 17, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 28, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Stargardt disease 3 Benign:2
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Spinocerebellar ataxia type 34 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
12
DANN
Benign
0.22
DEOGEN2
Benign
0.018
T
Eigen
Benign
-0.73
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.020
N
LIST_S2
Benign
0.094
T
MetaRNN
Benign
0.0043
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-0.81
N
PhyloP100
1.9
PrimateAI
Benign
0.37
T
PROVEAN
Benign
0.22
N
REVEL
Benign
0.076
Sift
Benign
1.0
T
Sift4G
Benign
0.81
T
Polyphen
0.0
B
Vest4
0.021
MPC
0.38
ClinPred
0.0020
T
GERP RS
5.6
Varity_R
0.11
gMVP
0.22
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3812153; hg19: chr6-80626375; COSMIC: COSV63953522; API